CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.1990
-0.0010 (-0.50%)
Jul 27, 2026, 3:57 PM EST
CytoDyn Cash Flow Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Net Income | -38.79 | 3.75 | -49.84 | -79.82 | -210.82 | -176.47 |
Depreciation & Amortization | 0.02 | 0.02 | 0.03 | 0.18 | 0.78 | 1.8 |
Other Amortization | 0.06 | 0.41 | 1.65 | 2.2 | 3.05 | 3.66 |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 10.05 |
Stock-Based Compensation | 1.41 | 1.61 | 2.42 | 4.28 | 6.24 | 10.43 |
Other Operating Activities | 1.93 | 1.63 | 23.11 | 49.26 | 127.81 | 58.08 |
Change in Inventory | - | - | - | - | 2.06 | -79.36 |
Change in Accounts Payable | 15.47 | -11.33 | 10.77 | -3.1 | -2.71 | 53.01 |
Change in Other Net Operating Assets | 1.93 | -4.84 | 0.89 | 1.9 | -4.13 | 1.23 |
Operating Cash Flow | -17.98 | -8.77 | -10.98 | -25.11 | -77.72 | -117.57 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Capital Expenditures | - | - | - | - | - | -0.12 |
Investing Cash Flow | - | - | - | - | - | -0.12 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Long-Term Debt Issued | - | - | 2.31 | 0.9 | - | 100 |
Total Debt Issued | - | - | 2.31 | 0.9 | - | 100 |
Long-Term Debt Repaid | - | -0.71 | - | - | - | -0.95 |
Total Debt Repaid | -0.14 | -0.71 | - | - | - | -0.95 |
Net Debt Issued (Repaid) | -0.14 | -0.71 | 2.31 | 0.9 | - | 99.05 |
Issuance of Common Stock | 16.51 | 1.19 | 9.44 | 26.23 | 42.62 | 22.27 |
Repurchase of Common Stock | - | - | - | - | - | -0.78 |
Preferred Dividends Paid | - | - | - | - | - | -0.24 |
Dividends Paid | - | - | - | - | - | -0.24 |
Other Financing Activities | 0.87 | 10.38 | - | 2.81 | 5.39 | 17.05 |
Financing Cash Flow | 17.24 | 10.85 | 11.75 | 29.93 | 48.01 | 137.35 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Net Cash Flow | -0.75 | 2.09 | 0.77 | 4.82 | -29.71 | 19.65 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Free Cash Flow | -17.98 | -8.77 | -10.98 | -25.11 | -77.72 | -117.7 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | - | - | -29219.17% | - |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.03 | -0.12 | -0.20 |
Levered Free Cash Flow | -4.85 | -4.3 | -43.19 | -31.93 | -102.87 | 15.22 |
Unlevered Free Cash Flow | -3.05 | -1.67 | -39.28 | -24.44 | -90.8 | 25.38 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Cash Interest Paid | 0.02 | 0.03 | 0.05 | 0.02 | 0.06 | 0.15 |
Change in Working Capital | 17.4 | -16.17 | 11.66 | -1.2 | -4.78 | -25.12 |